SB22-027
Prescription Drug Monitoring Program
| Type | Bill |
|---|---|
| Session | 2022 Regular Session |
| Subjects |
Concerning changes to the prescription drug monitoring program pursuant to the March 2021 audit report issued by the office of the state auditor.
Bill Summary:
The act clarifies that:
- Each prescriber of prescription drugs must register and maintain a user account with the prescription drug monitoring program (program); and
- Each licensed health-care practitioner must query the program prior to filling a prescription for every opioid or benzodiazepine.
The act requires the group tasked with developing a strategic plan to reduce prescription drug misuse to evaluate and make recommendations to the executive director of the department of regulatory agencies regarding balancing the use of the program as a health-care tool with enforcement of the requirements of the program.
(Note: This summary applies to this bill as enacted.)
Related Documents & Information
| Date | Version | Documents |
|---|---|---|
| 05/03/2022 | PA1 |
| Activity | Vote | Documents |
|---|---|---|
| Adopt amendment L.003 (Attachment B). | The motion passed without objection. | Vote summary |
| Refer Senate Bill 22-027, as amended, to the Committee of the Whole. | The motion passed on a vote of 8-2. | Vote summary |
| Activity | Vote | Documents |
|---|---|---|
| Refer Senate Bill 22-027 to the Committee of the Whole and with a recommendation that it be placed on the consent calendar. | The motion passed on a vote of 7-0. | Vote summary |
| Date | Calendar | Motion | Vote | Vote Document |
|---|---|---|---|---|
| 05/09/2022 | House Amendments | REPASS |
35
AYE
0
NO
0
OTHER
|
Vote record |
| 05/09/2022 | House Amendments | CONCUR |
35
AYE
0
NO
0
OTHER
|
Vote record |
| 02/15/2022 | Third Reading | BILL |
34
AYE
0
NO
1
OTHER
|
Vote record |
| Date | Calendar | Motion | Vote | Vote Document |
|---|---|---|---|---|
| 05/06/2022 | Third Reading | BILL |
56
AYE
7
NO
2
OTHER
|
Vote record |
| Date | Amendment Number | Committee/ Floor Hearing | Status | Documents |
|---|---|---|---|---|
| 05/02/2022 | L.003 | HOU Health & Insurance | Passed [*] |
| Date | Location | Action |
|---|---|---|
| 05/27/2022 | Governor | Governor Signed |
| 05/18/2022 | Governor | Sent to the Governor |
| 05/18/2022 | House | Signed by the Speaker of the House |
| 05/18/2022 | Senate | Signed by the President of the Senate |
| 05/09/2022 | Senate | Senate Considered House Amendments - Result was to Concur - Repass |
| 05/06/2022 | House | House Third Reading Passed - No Amendments |
| 05/04/2022 | House | House Third Reading Laid Over Daily - No Amendments |
| 05/03/2022 | House | House Second Reading Special Order - Passed with Amendments - Committee |
| 05/02/2022 | House | House Committee on Health & Insurance Refer Amended to House Committee of the Whole |
| 02/16/2022 | House | Introduced In House - Assigned to Health & Insurance |
| 02/15/2022 | Senate | Senate Third Reading Passed - No Amendments |
| 02/14/2022 | Senate | Senate Second Reading Passed - No Amendments |
| 02/09/2022 | Senate | Senate Committee on Health & Human Services Refer Unamended - Consent Calendar to Senate Committee of the Whole |
| 01/12/2022 | Senate | Introduced In Senate - Assigned to Health & Human Services |
Prime Sponsor
Sponsor
(None)
Co-Sponsor
| Effective Date | Chapter # | Title | Documents |
|---|---|---|---|
| 05/27/2022 | 265 | Prescription Drug Monitoring Program |